Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens

NCT01854099 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Investigator decided not to open study.

Conditions

Interventions

Sponsor

University of Florida

Collaborators